Research ArticleTechnology/Application
An Improved Impact Ratio for Identifying Critical Process Parameters in Pharmaceutical Manufacturing Processes
Jens Lamerz, Oana Mihaela Danila, Andreas Schuster, Janine Burren, Christian Moessner, Wolfgang Göhring, Pankaj Rege, Helmut Stahr, Stefan Hildbrand and Daniel Coleman
PDA Journal of Pharmaceutical Science and Technology November 2022, 76 (6) 497-508; DOI: https://doi.org/10.5731/pdajpst.2021.012662
Jens Lamerz
1Nonclinical Biostatistics, F. Hoffmann-La Roche Ltd, Basel, Switzerland;
Oana Mihaela Danila
1Nonclinical Biostatistics, F. Hoffmann-La Roche Ltd, Basel, Switzerland;
Andreas Schuster
2Process Chemistry & Catalysis, Synthetic Molecules Technical Development, F. Hoffmann-La Roche Ltd, Basel, Switzerland;
Janine Burren
1Nonclinical Biostatistics, F. Hoffmann-La Roche Ltd, Basel, Switzerland;
Christian Moessner
2Process Chemistry & Catalysis, Synthetic Molecules Technical Development, F. Hoffmann-La Roche Ltd, Basel, Switzerland;
Wolfgang Göhring
2Process Chemistry & Catalysis, Synthetic Molecules Technical Development, F. Hoffmann-La Roche Ltd, Basel, Switzerland;
Pankaj Rege
3Pharma Technical Regulatory, F. Hoffmann-La Roche Ltd, Basel, Switzerland; and
Helmut Stahr
2Process Chemistry & Catalysis, Synthetic Molecules Technical Development, F. Hoffmann-La Roche Ltd, Basel, Switzerland;
Stefan Hildbrand
2Process Chemistry & Catalysis, Synthetic Molecules Technical Development, F. Hoffmann-La Roche Ltd, Basel, Switzerland;
Daniel Coleman
4Nonclinical Biostatistics, Genentech, Inc., South San Francisco, CA, USA
References
- 1.↵
- 2.↵
- Jameel F.
- Hershenson S.
- Khan M.
- Martin-Moe M.
- Taticek R.,
- Liu J.
- 3.↵
- Bhatia H.,
- Read E.,
- Agarabi C.,
- Brorson K.,
- Lute S.,
- Yoon S.
- 4.↵International Conference for Harmonisation, Quality Guideline Q8(R2): Pharmaceutical Development. ICH: Geneva, 2009.
- 5.↵
- 6.↵
- Marasco D. M.,
- Gao J.,
- Griffiths K.,
- Froggatt C.,
- Wang T.,
- Wei G.
- 7.↵
- Wang K.,
- Ide N. D.,
- Dirat O.,
- Subashi A. K.,
- Thomson N. M.,
- Vukovinsky K. E.,
- Watson T. J.
- 8.↵
- Li F.,
- Evans B.,
- Liu F.,
- Zhang J.,
- Wang K.,
- Cheng A.
- 9.↵
- Hakemeyer C.,
- McKnight N.,
- St John R.,
- Meier S.,
- Trexler-Schmidt M.,
- Kelley B.,
- Zettl F.,
- Puskeiler R.,
- Kleinjans A.,
- Lim F.,
- Wurth C.
- 10.↵NIST/SEMATECH e-Handbook of Statistical Methods. http://www.itl.nist.gov/div898/handbook (accessed June 15, 2021).
- 11.↵
- Montgomery D.
- 12.↵
- Wang J. C.,
- Wu C. F. J.
- 13.↵
- Abe Y.,
- Emori K.
In This Issue
PDA Journal of Pharmaceutical Science and Technology
Vol. 76, Issue 6
November/December 2022
An Improved Impact Ratio for Identifying Critical Process Parameters in Pharmaceutical Manufacturing Processes
Jens Lamerz, Oana Mihaela Danila, Andreas Schuster, Janine Burren, Christian Moessner, Wolfgang Göhring, Pankaj Rege, Helmut Stahr, Stefan Hildbrand, Daniel Coleman
PDA Journal of Pharmaceutical Science and Technology Nov 2022, 76 (6) 497-508; DOI: 10.5731/pdajpst.2021.012662
An Improved Impact Ratio for Identifying Critical Process Parameters in Pharmaceutical Manufacturing Processes
Jens Lamerz, Oana Mihaela Danila, Andreas Schuster, Janine Burren, Christian Moessner, Wolfgang Göhring, Pankaj Rege, Helmut Stahr, Stefan Hildbrand, Daniel Coleman
PDA Journal of Pharmaceutical Science and Technology Nov 2022, 76 (6) 497-508; DOI: 10.5731/pdajpst.2021.012662
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.
More in this TOC Section
Similar Articles
Keywords